article

Drug Target Review – Issue 1 2021

Posted: 25 March 2021 | | No comments yet

In this issue, find articles discussing how high-throughput experimentation can enhance automated molecular discovery, why bNAbs present a promising COVID-19 treatment and how a novel rhinovirus vaccine was developed. Also included are features on immuno-oncology, cell line development and assays. 

Drug Target Review Issue 1 2021

Included in this issue:

  • VACCINE DEVELOPMENT
    The development of biomaterial-based vaccine platforms against viruses
    Dr Sushma Kumari, Dr Sonal Asthana and Dr Kaushik Chatterjee, Indian Institute of Science
  • CELL LINE DEVELOPMENT
    Which CHO cell is the right CHO cell?
    Dr Louis Boon, Polpharma Biologics Utrecht
  • ANTIBODIES
    Fighting HIV: could antibodies be the answer?

    Victoria Rees, Drug Target Review
  • LAB AUTOMATION 
    Expanding accessible chemical space through automated high-throughput experimentation
    Dr Sam Liver, The Rosalind Franklin Institute
  • ASSAYS
    COVID-19 drug targets and cell-based assays
    Sheraz Gul, Fraunhofer Institute and Alp Tegin Sahin, Kadir Has University
  • LIPIDOMICS
    Synthesising very long-chain fatty acids to treat retinal conditions
    Dr Paul Bernstein, University of Utah

The rest of this content is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 


Send this to a friend